ST CHARLES MADRAS — History
CCN 381324 | 3-year financial timeline | COVID resilience: 80/100
🛡️ Public data only — no PHI permitted on this instance.
$53M
Latest Revenue (FY2022)
+24.6%
Revenue CAGR (3yr)
16.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $34M | $44M | $53M | +20.5% | +24.6% |
| Operating Expenses | $34M | $38M | $44M | +16.2% | +14.1% |
| Operating Margin | 0.9% | 13.7% | 16.9% | +22.8% | +344.8% |
| Net Income | $0M | $6M | $9M | +48.0% | +454.1% |
| Licensed Beds | 25 | 25 | 24 | -4.0% | -2.0% |
| Total Patient Days | 3,551 | 4,757 | 3,877 | -18.5% | +4.5% |
| Medicare Day % | 41% | 41% | 34% | -16.3% | -9.3% |
| Medicaid Day % | 19% | 9% | 14% | +47.3% | -14.8% |
COVID Impact & Recovery
Resilience Score: 80/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +55.2% ($34M → $53M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+24.6%
This Hospital
+7.6%
State Avg
Latest Margin
16.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $62M | 24.9% |
| FY2024 (proj) | $71M | 32.9% |
| FY2025 (proj) | $81M | 40.9% |